United Nations set to tackle the spread of non-communicable diseases

17 May 2010

The World Health Organization says it welcomes the adoption last week of the United Nations General Assembly resolution on the prevention and control of non-communicable diseases - mainly cardiovascular diseases, cancers, chronic respiratory diseases and diabetes - which kill nearly 35 million people each year, including almost 9 million before the age of 60. The resolution seeks to halt the increasing trends in premature deaths from non-communicable diseases worldwide.

"There is a sense of urgency," says WHO Assistant Director-General Ala Alwan, noting that "it will help us increase action to address the leading cause of death in the world. Tackling these diseases constitutes one of the major challenges for sustainable development in the twenty-first century."

Access to essential medicines cited

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical